The following are important treatment considerations for you to discuss with your physician and understand in order to help avoid unsatisfactory results and complications.
•Patients who are using substances that can prolong bleeding, such as aspirin or ibuprofen, as with any injection, may experience increased bruising or bleeding at injection site. You should inform your physician before treatment if you are using these types of substances.
•If laser treatment, chemical peeling, or any other procedure based on active dermal response is considered after treatment with Devolux, there is a possible risk of an inflammatory reaction at the treatment site.
•Devolux inject able should be used with caution in patients on immunosuppressive therapy, or therapy used to decrease the body’s immune response, as there may be an increased risk of infection.
•The safety for use during pregnancy, in breast-feeding females, or in patients under 18 years has not been established.
•The safety in patients with a history of excessive scarring (such as hypertrophic scarring and keloid formations) and pigmentation disorders has not been studied.
•People with scars constitution should use it with caution.
•Severe allergies marked by a history of anaphylaxis or presence of multiple severe allergies should not receive Devolux injection.
• A history of allergies of corn or fermented PLLA(Poly L Lactic Acid).
